Select Page

ENGINEERING

LIVING MEDICINES

FOR CHRONIC DISEASES

[

We don’t discover drugs.
We build them.

The future of medicine is cellular. We engineer cell therapies to outsmart chronic diseases. Therapies that are precise, extensible, and act symbiotically with the patient to achieve long-term health. Beyond smart, our therapies are alive.

Timeline
^

4Q21

Georgia Safety / Efficacy Trial
N=20 (On Meds)
.
^

4Q21/1Q22

FDA Meetings for US Pivotal Trial
^

1Q22/2Q22

Financing Raise for US Pivotal Trial
Powered by Georgia End Points
^

3Q22

Initiate US Pivotal Trial
Consider separate Off Meds Trial

Management Team

David Springer

President and CEO

Terry Buelna

Founder and CTO 

Randy Buness

CFO

Derek Harper

VP of Research & Development

Shima Hashemian

VP of Regulatory Affairs & Quality Assurance

Advisors Team

Steve Gex

Board Chairman

Dr. Ralph Clayman

Scientific Advisor

Dr. Richard Heuser

Scientific Advisor 

Dr. Gopal Badlani

Scientific Advisor

Dr. Michael Weber

Scientific Advisor

Piter McCain

Scientific Advisor

Dr. Ulla Kopp

Scientific Advisor

Dr. Glenn Preminger

Scientific Advisor

Dr. Dagmara Hering

Scientific Advisor

Dr. Robert Provenzano

Scientific Advisor